.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Federal Trade Commission
Cerilliant
UBS
Citi
McKinsey
Daiichi Sankyo
Julphar
Covington
Medtronic

Generated: December 16, 2017

DrugPatentWatch Database Preview

BELSOMRA Drug Profile

« Back to Dashboard

Which patents cover Belsomra, and when can generic versions of Belsomra launch?

Belsomra is a drug marketed by Merck Sharp Dohme and is included in one NDA. There is one patent protecting this drug.

This drug has fifty-four patent family members in thirty-five countries.

The generic ingredient in BELSOMRA is suvorexant. One supplier is listed for this compound. Additional details are available on the suvorexant profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck Sharp DohmeBELSOMRAsuvorexantTABLET;ORAL204569-001Aug 13, 2014RXYesNo► Subscribe► SubscribeYY► Subscribe
Merck Sharp DohmeBELSOMRAsuvorexantTABLET;ORAL204569-004Aug 13, 2014RXYesYes► Subscribe► SubscribeYY► Subscribe
Merck Sharp DohmeBELSOMRAsuvorexantTABLET;ORAL204569-002Aug 13, 2014RXYesNo► Subscribe► Subscribe► Subscribe
Merck Sharp DohmeBELSOMRAsuvorexantTABLET;ORAL204569-004Aug 13, 2014RXYesYes► Subscribe► Subscribe► Subscribe
Merck Sharp DohmeBELSOMRAsuvorexantTABLET;ORAL204569-001Aug 13, 2014RXYesNo► Subscribe► Subscribe► Subscribe
Merck Sharp DohmeBELSOMRAsuvorexantTABLET;ORAL204569-002Aug 13, 2014RXYesNo► Subscribe► SubscribeYY► Subscribe
Merck Sharp DohmeBELSOMRAsuvorexantTABLET;ORAL204569-003Aug 13, 2014RXYesNo► Subscribe► Subscribe► Subscribe
Merck Sharp DohmeBELSOMRAsuvorexantTABLET;ORAL204569-003Aug 13, 2014RXYesNo► Subscribe► SubscribeYY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: BELSOMRA

Country Document Number Estimated Expiration
Mexico2009005712► Subscribe
Morocco31016► Subscribe
Malaysia161834► Subscribe
El Salvador2009003276► Subscribe
Norway20092470► Subscribe
South Korea101299426► Subscribe
New Zealand577334► Subscribe
European Patent Office2089382► Subscribe
Ukraine100974► Subscribe
Serbia52617► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Federal Trade Commission
Deloitte
Dow
Harvard Business School
QuintilesIMS
Chubb
Julphar
US Army
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot